ABVC BioPharma (ABVC) Revenue & Revenue Breakdown
ABVC BioPharma Revenue Highlights
Latest Revenue (Y)
$152.43K
Latest Revenue (Q)
$117.14K
ABVC BioPharma Revenue by Period
ABVC BioPharma Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | -84.28% |
2022-12-31 | - | 172.57% |
2021-12-31 | - | -26.34% |
2020-12-31 | - | -31.16% |
2019-12-31 | - | 9987.97% |
2018-12-31 | - | 117.65% |
2017-12-31 | - | 9887.50% |
2016-09-30 | - | -99.05% |
2015-09-30 | - | 100.00% |
2014-09-30 | - | -100.00% |
2013-09-30 | - | 36.28% |
2012-09-30 | - | 79.12% |
2011-09-30 | - | -78.53% |
2010-09-30 | - | 100.00% |
2009-09-30 | - | -100.00% |
2008-09-30 | - | -39.78% |
2007-09-30 | - | 100.00% |
2006-12-31 | - | 100.00% |
2005-12-31 | - | -100.00% |
2004-12-31 | - | 320.59% |
2003-12-31 | - | 36.70% |
2002-12-31 | - | - |
ABVC BioPharma Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-06-30 | - | 9621.33% |
2024-03-31 | - | -44.34% |
2023-12-31 | - | -86.37% |
2023-09-30 | - | 160.01% |
2023-06-30 | - | -95.24% |
2023-03-31 | - | -78.22% |
2022-12-31 | - | 1293.44% |
2022-09-30 | - | -86.49% |
2022-06-30 | - | 1119.25% |
2022-03-31 | - | -167.90% |
2021-12-31 | - | -138.18% |
2021-09-30 | - | 214.87% |
2021-06-30 | - | -88.05% |
2021-03-31 | - | 323.12% |
2020-12-31 | - | -46.18% |
2020-09-30 | - | -48.99% |
2020-06-30 | - | 187.50% |
2020-03-31 | - | -21.18% |
2019-12-31 | - | -49.45% |
2019-09-30 | - | 3.10% |
2019-06-30 | - | -9.64% |
2019-03-31 | - | 7022.21% |
2018-12-31 | - | 298.93% |
2018-09-30 | - | -76.87% |
2018-06-30 | - | 100.00% |
2018-03-31 | - | 100.00% |
2017-12-31 | - | 100.00% |
2017-09-30 | - | 100.00% |
2017-06-30 | - | 100.00% |
2017-03-31 | - | -100.00% |
2016-12-31 | - | 100.00% |
2016-09-30 | - | 100.00% |
2016-06-30 | - | -100.00% |
2016-03-31 | - | 100.00% |
2015-12-31 | - | -100.00% |
2015-09-30 | - | 100.00% |
2015-06-30 | - | 100.00% |
2015-03-31 | - | 100.00% |
2014-12-31 | - | 100.00% |
2014-09-30 | - | 100.00% |
2014-06-30 | - | 100.00% |
2014-03-31 | - | 100.00% |
2013-12-31 | - | 100.00% |
2013-09-30 | - | 100.00% |
2013-06-30 | - | -100.00% |
2013-03-31 | - | -89.17% |
2012-12-31 | - | 100.00% |
2012-09-30 | - | 100.00% |
2012-05-14 | - | -100.00% |
2012-02-20 | - | 78.87% |
2011-12-15 | - | 100.00% |
2011-08-03 | - | 100.00% |
2011-06-30 | - | -100.00% |
2011-02-13 | - | -70.85% |
2011-01-12 | - | 115.53% |
2010-08-15 | - | -59.49% |
2010-06-30 | - | -47.88% |
2010-03-31 | - | 100.00% |
2009-09-30 | - | 100.00% |
2009-06-30 | - | 100.00% |
2009-03-31 | - | -100.00% |
2008-12-31 | - | 2523.56% |
2008-09-30 | - | -94.86% |
2008-06-30 | - | -61.12% |
2008-03-31 | - | - |
ABVC BioPharma Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
SABS | SAB Biotherapeutics | - | - |
NTRB | Nutriband | - | - |
LGVN | Longeveron | - | - |
ADTX | Aditxt | - | - |
MGTA | Dianthus Therapeutics | - | - |
ABVC | ABVC BioPharma | - | - |
VRAX | Virax Biolabs Group | - | - |
ANEB | Anebulo Pharmaceuticals | - | - |
APTX | Aptinyx | - | - |
FBRX | Forte Biosciences | - | - |
EVLO | Evelo Biosciences | - | - |
ALRN | Aileron Therapeutics | - | - |
AKTX | Akari Therapeutics | - | - |
ARDS | Aridis Pharmaceuticals | - | - |
RNXT | RenovoRx | - | - |
MNPR | Monopar Therapeutics | - | - |
INDP | Indaptus Therapeutics | - | - |
QNRX | Quoin Pharmaceuticals | - | - |
ELDN | Eledon Pharmaceuticals | - | - |
KTTA | Pasithea Therapeutics | - | - |
ACST | Acasti Pharma | - | - |